Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roy D Bloom

Showing results (41-50 of 124) with videos related to

Pageof 13
Sort By:
Therapeutic Drug Monitoring|March 11, 2010
Mycophenolic acid exposure in high- and low-weight renal transplant patients after dosing with mycophenolate mofetil in the Opticept trialBruce Kaplan, Robert S Gaston, Herwig-Ulf Meier-Kriesche, et al.
Clinics in Chest Medicine|November 3, 2005
An overview of solid organ transplantationRoy D Bloom, Lee R Goldberg, Andrew Y Wang, et al.
Clinical Journal of the American Society of Nephrology : CJASN|August 21, 2007
Nephrotic syndrome after hematopoietic cell transplantation: do glomerular lesions represent renal graft-versus-host disease?Kirsten Brukamp, Alden M Doyle, Roy D Bloom, et al.
Journal of the American Society of Nephrology : JASN|April 19, 2002
Association of hepatitis C with posttransplant diabetes in renal transplant patients on tacrolimusRoy D Bloom, Vinaya Rao, Francis Weng, et al.
Journal of the American Society of Nephrology : JASN|October 13, 2006
Posttransplantation anemia at 12 months in kidney recipients treated with mycophenolate mofetil: risk factors and implications for mortalityAnikphe E Imoagene-Oyedeji, Sylvia E Rosas, Alden M Doyle, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|April 3, 2009
Methotrexate clearance by high-flux hemodialysis and peritoneal dialysis: a case reportMiho Murashima, Jill Adamski, Michael C Milone, et al.
Journal of the American Geriatrics Society|September 14, 2010
How should we use age to ration health care? Lessons from the case of kidney transplantationPeter P Reese, Arthur L Caplan, Roy D Bloom, et al.
Transplantation|April 28, 2006
24-week oral ganciclovir prophylaxis in kidney recipients is associated with reduced symptomatic cytomegalovirus disease compared to a 12-week courseAlden M Doyle, Karen M Warburton, Simin Goral, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|June 11, 2016
Long-term patient survival and kidney allograft survival in post-transplant diabetes mellitus: a single-center retrospective studyThomas Dienemann, Naohiko Fujii, Yimei Li, et al.
Transplantation|September 11, 2009
Short-term outcomes for obese live kidney donors and their recipientsPeter P Reese, Harold I Feldman, David A Asch, et al.
Pageof 13

Showing results (41-50 of 124) with videos related to

Sort By:
Pageof 13
Therapeutic Drug Monitoring|March 11, 2010
Mycophenolic acid exposure in high- and low-weight renal transplant patients after dosing with mycophenolate mofetil in the Opticept trialBruce Kaplan, Robert S Gaston, Herwig-Ulf Meier-Kriesche, et al.
Clinics in Chest Medicine|November 3, 2005
An overview of solid organ transplantationRoy D Bloom, Lee R Goldberg, Andrew Y Wang, et al.
Clinical Journal of the American Society of Nephrology : CJASN|August 21, 2007
Nephrotic syndrome after hematopoietic cell transplantation: do glomerular lesions represent renal graft-versus-host disease?Kirsten Brukamp, Alden M Doyle, Roy D Bloom, et al.
Journal of the American Society of Nephrology : JASN|April 19, 2002
Association of hepatitis C with posttransplant diabetes in renal transplant patients on tacrolimusRoy D Bloom, Vinaya Rao, Francis Weng, et al.
Journal of the American Society of Nephrology : JASN|October 13, 2006
Posttransplantation anemia at 12 months in kidney recipients treated with mycophenolate mofetil: risk factors and implications for mortalityAnikphe E Imoagene-Oyedeji, Sylvia E Rosas, Alden M Doyle, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|April 3, 2009
Methotrexate clearance by high-flux hemodialysis and peritoneal dialysis: a case reportMiho Murashima, Jill Adamski, Michael C Milone, et al.
Journal of the American Geriatrics Society|September 14, 2010
How should we use age to ration health care? Lessons from the case of kidney transplantationPeter P Reese, Arthur L Caplan, Roy D Bloom, et al.
Transplantation|April 28, 2006
24-week oral ganciclovir prophylaxis in kidney recipients is associated with reduced symptomatic cytomegalovirus disease compared to a 12-week courseAlden M Doyle, Karen M Warburton, Simin Goral, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|June 11, 2016
Long-term patient survival and kidney allograft survival in post-transplant diabetes mellitus: a single-center retrospective studyThomas Dienemann, Naohiko Fujii, Yimei Li, et al.
Transplantation|September 11, 2009
Short-term outcomes for obese live kidney donors and their recipientsPeter P Reese, Harold I Feldman, David A Asch, et al.
Pageof 13